Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
Having a prostate-specific antigen (PSA) test result above 4.0 ng/mL is considered abnormal and it is worth closer testing, a physician said yesterday, as he suggested individuals with a family ...
Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...
THOMASVILLE — Archbold Urology is committed to offering patients in the region access to the most advanced treatments for urologic conditions that affect many of its neighbors.
Partners and family members could be the first to notice ...
We came across a bullish thesis on PROCEPT BioRobotics Corporation on Notes From The Beauty Contest’s Substack by ...
Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased ...
Men from across Surrey are set to benefit from a major investment in leading medical technology at Nuffield Health Woking Hospital, as the hospital launches Aquablation therapy for patients suffering ...
Profound Medical (NASDAQ:PROF) reported fourth-quarter 2025 revenue of $6.0 million, including $2.3 million in recurring ...
In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...
Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results